Infusion of autologous alloactivated lymphocytes in melanoma patients: toxicity and immunologic monitoring.

MLA

Gambacorti-Passerini, C., et al. “Infusion of Autologous Alloactivated Lymphocytes in Melanoma Patients: Toxicity and Immunologic Monitoring.” Tumori, vol. 72, no. 4, Aug. 1986, pp. 383–88. EBSCOhost, https://doi.org/10.1177/030089168607200407.

APA

Gambacorti-Passerini, C., Marolda, R., Tona, G., Sciorelli, G., Fossati, G., Cascinelli, N., & Parmiani, G. (1986). Infusion of autologous alloactivated lymphocytes in melanoma patients: toxicity and immunologic monitoring. Tumori, 72(4), 383–388. https://doi.org/10.1177/030089168607200407

Chicago

Gambacorti-Passerini, C, R Marolda, G Tona, G Sciorelli, G Fossati, N Cascinelli, and G Parmiani. 1986. “Infusion of Autologous Alloactivated Lymphocytes in Melanoma Patients: Toxicity and Immunologic Monitoring.” Tumori 72 (4): 383–88. doi:10.1177/030089168607200407.